TILT Holdings Inc.
General ticker "TLLTF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.7M (TTM average)
TILT Holdings Inc. does not follow the US Stock Market performance with the rate: -8.7%.
Estimated limits based on current volatility of 0.3%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 358 (-18.1%) as of 2023
- US accounted for 87.8% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Regulatory and compliance, Liquidity and credit risks, Cash flow risks, Labor/talent shortage/retention, Product recalls
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.00$, 0.02$]
- 2025-12-31 to 2026-12-31 estimated range: [0.01$, 0.02$]
Financial Metrics affecting the TLLTF estimates:
- Positive: with PPE of -0.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Positive: Inventory ratio change, % of -0.26 <= 0
- Negative: Operating cash flow per share per price, % of -7.77 <= 0.33
Short-term TLLTF quotes
Long-term TLLTF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $174.19MM | $165.96MM | $115.61MM |
| Operating Expenses | $202.91MM | $209.11MM | $185.04MM |
| Operating Income | $-28.72MM | $-43.15MM | $-69.43MM |
| Non-Operating Income | $-75.74MM | $-24.00MM | $-25.52MM |
| Interest Expense | $14.24MM | $21.00MM | $26.39MM |
| Income(Loss) | $-104.46MM | $-67.16MM | $-94.94MM |
| Taxes | $3.01MM | $-3.34MM | $4.72MM |
| Profit(Loss)* | $-107.46MM | $-62.38MM | $-94.88MM |
| Stockholders Equity | $121.35MM | $62.39MM | $-37.20MM |
| Inventory | $52.91MM | $32.91MM | $22.49MM |
| Assets | $293.98MM | $231.19MM | $151.32MM |
| Operating Cash Flow | $8.61MM | $5.37MM | $-0.19MM |
| Capital expenditure | $15.14MM | $0.71MM | $0.89MM |
| Investing Cash Flow | $-16.84MM | $13.17MM | $-0.74MM |
| Financing Cash Flow | $4.78MM | $-18.69MM | $1.91MM |
| Earnings Per Share** | $-0.29 | $-0.16 | $-0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.